Madden Martin J. 4
4 · NovoCure Ltd · Filed Jun 9, 2023
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Madden Martin J.
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-07+12,554→ 12,554 totalExercise: $48.66From: 2024-06-07Exp: 2033-06-06→ Ordinary Shares (12,554 underlying)
Footnotes (1)
- [F1]Options to buy 12,554 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2024 annual general meeting of shareholders.